C47H41N5O4 — CID 174304221
2-[8-[(4-carbamimidoylphenyl)-methylcarbamoyl]-1-(chrysen-1-ylmethyl)-3-oxo-4-(2-phenylethyl)-2,5-dihydro-1,4-benzodiazepin-2-yl]acetic acid (PubChem CID 174304221) has the molecular formula C47H41N5O4 and a molecular weight of 739.88 g/mol. Its IUPAC name is 2-[8-[(4-carbamimidoylphenyl)-methylcarbamoyl]-1-(chrysen-1-ylmethyl)-3-oxo-4-(2-phenylethyl)-2,5-dihydro-1,4-benzodiazepin-2-yl]acetic acid.
| Compound Name | 2-[8-[(4-carbamimidoylphenyl)-methylcarbamoyl]-1-(chrysen-1-ylmethyl)-3-oxo-4-(2-phenylethyl)-2,5-dihydro-1,4-benzodiazepin-2-yl]acetic acid |
|---|---|
| PubChem CID | 174304221 |
| Molecular Formula | C47H41N5O4 |
| Molecular Weight | 739.88 g/mol |
| Exact Mass | 739.32 |
| IUPAC Name | 2-[8-[(4-carbamimidoylphenyl)-methylcarbamoyl]-1-(chrysen-1-ylmethyl)-3-oxo-4-(2-phenylethyl)-2,5-dihydro-1,4-benzodiazepin-2-yl]acetic acid |
| SMILES | [H]/N=C(\N)c1ccc(N(C)C(=O)c2ccc3c(c2)N(Cc2cccc4c2ccc2c5ccccc5ccc42)C(CC(=O)O)C(=O)N(CCc2ccccc2)C3)cc1 |
| InChI | InChI=1S/C47H41N5O4/c1-50(36-19-16-32(17-20-36)45(48)49)46(55)33-14-15-35-28-51(25-24-30-8-3-2-4-9-30)47(56)43(27-44(53)54)52(42(35)26-33)29-34-11-7-13-39-38(34)22-23-40-37-12-6-5-10-31(37)18-21-41(39)40/h2-23,26,43H,24-25,27-29H2,1H3,(H3,48,49)(H,53,54) |
| InChIKey | YABXOKLVMLVCRL-UHFFFAOYSA-N |
| XLogP | 8.14 |
| TPSA | 131.03 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 56 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 739.88 |
| LogP ≤ 5 | 8.14 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|